Every 3 seconds someone in the world develops dementia.
At the heart of AI-Mind are two artificial intelligence based digital tools that will be integrated into a cloud-based diagnostic support platform. These tools will analyse existing and routinely collected data in an innovative manner: the AI-Mind Connector will fully automate the identification of early brain network disturbances; after enriching data from AI-Mind Connector with genetic and cognitive information, AI-Mind Predictor will provide an early marker of risk for dementia in people with MCI.
The dementia patient journey at the moment involves several clinical visits, which finally result in a diagnosis of dementia two to five years after initial symptoms. AI-Mind will shorten the time to diagnosis to a week and allow for diagnosis at the MCI stage, when there are no severe structural cerebral defects and intervention is still possible. AI-Mind will extend the ‘dementia-free’ period among MCI-patients who are prodromal to dementia by offering diagnosis and early intervention.
AI-Mind will disrupt the clinical setting and significantly impact patients’ and doctors’ diagnostic journeys. Physicians will have a supportive decision-making tool that is able to identify patients at risk of developing dementia with high probability.
Did you know that one in four people believes that dementia is not preventable and two of three people think that dementia is a normal part of the ageing process? Ninety-five percent of the public assume that they will develop dementia in their lifetime. More importantly, 82% of respondents have indicated that they would take a genetic test to learn about their risk of developing dementia. There is also a high chance that individuals will have to care for a person with dementia in their lifetime. Therefore, the need for early risk assessment and intervention is prevalent. AI-Mind aims to have a high impact on the personal lives of the European public over time.
AI-Mind is an European project receiving funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 964220. It is a five-year Research and Innovation Action (RIA) that officially starts in March 2021. It involves fifteen project partners from eight European countries and has a budget around 14 million euro.
The AI-Mind project addresses the Horizon 2020 Call H2020-SC1-BHC-06-2020, ‘Digital diagnostics – developing tools for supporting clinical decisions by integrating various diagnostic data,’ by developing a decision support diagnostics platform for early risk estimation of dementia through two BSOA AI-based tools using SOA data.